CD8A and colorectal cancer: An immunoscore based on measures of the density of CD3+ and CD8+ TIL has been validated in a worldwide collaborative study involving more than 4000 patients with solid cancer and showed superior prognostic performance as compared with standard prognosticators in colorectal cancer [32,33].